INCLUSIVE
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu
4376
Cube
7112
(Q2)2024/08/31 | (Q1)2024/05/31 | (FY)2024/02/29 | (Q4)2024/02/29 | (Q3)2023/11/30 | (Q2)2023/08/31 | (Q1)2023/05/31 | (FY)2023/02/28 | (Q4)2023/02/28 | (Q3)2022/11/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 33.52%39.03億 | 42.22%42.57億 | 10.17%126.26億 | 6.32%37.23億 | 28.51%29.86億 | 21.52%29.23億 | -7.31%29.94億 | -2.83%114.61億 | -5.91%35.02億 | -5.24%23.23億 |
主營業務成本 | 41.44%32.59億 | 38.65%33.07億 | 11.14%101.08億 | 7.60%29.7億 | 29.63%24.48億 | 18.87%23.05億 | -4.87%23.85億 | -0.04%90.95億 | -2.72%27.6億 | -4.00%18.88億 |
毛利 | 4.01%6.43億 | 56.21%9.5億 | 6.44%25.18億 | 1.55%7.53億 | 23.65%5.38億 | 32.53%6.19億 | -15.77%6.08億 | -12.22%23.66億 | -16.17%7.42億 | -10.28%4.35億 |
營業費用 | 5.69%5.81億 | 4.76%5.65億 | 2.30%22.48億 | 3.93%5.59億 | 12.69%6億 | 1.85%5.5億 | -8.21%5.39億 | -17.09%21.97億 | -14.57%5.38億 | -17.43%5.33億 |
營業利潤 | -9.34%6,242.7萬 | 455.30%3.86億 | 60.36%2.71億 | -4.72%1.95億 | 36.14%-6,237.7萬 | 194.32%6,885.6萬 | -48.59%6,948.7萬 | 272.73%1.69億 | -20.10%2.04億 | 39.06%-9,768.4萬 |
營業外利息收入與支出淨額 | -42.24%-556.6萬 | -33.20%-528萬 | -0.70%-1,719萬 | -27.55%-518.5萬 | 4.71%-412.8萬 | 17.62%-391.3萬 | -1.02%-396.4萬 | 5.07%-1,707.1萬 | 1.79%-406.5萬 | 1.92%-433.2萬 |
營業外利息收入 | 11.11%18萬 | 352.50%18.1萬 | -8.76%22.9萬 | -18.18%1.8萬 | -50.00%9,000 | 500.00%16.2萬 | -78.26%4萬 | -14.04%25.1萬 | -37.14%2.2萬 | 5.88%1.8萬 |
營業外利息支出 | 41.01%574.6萬 | 36.39%546.1萬 | 0.56%1,741.9萬 | 27.31%520.3萬 | -4.90%413.7萬 | -14.70%407.5萬 | -2.53%400.4萬 | -5.21%1,732.2萬 | -2.08%408.7萬 | -1.89%435萬 |
投資淨收益 | 24.76%341.6萬 | 5.71%684.8萬 | 10.61%1,314.8萬 | 61.94%68.5萬 | 20.26%324.7萬 | 7.54%273.8萬 | 4.18%647.8萬 | 14.24%1,188.7萬 | 11.90%42.3萬 | 20.64%270萬 |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | -9,490.11%-1,745.4萬 | 0 | 0 | -115.04%-18.2萬 | 0 | 0 | ||||
聯營企業及其他參股權益產生的收益 | ||||||||||
特殊收入(費用) | 281.89%2.54億 | -101.79%-90萬 | 577,356.76%2.14億 | -11.12%6,646萬 | 1,653.12%5,022.8萬 | -100.06%-3.7萬 | ||||
減:其他特殊費用 | ---- | ---- | -281.89%-2.54億 | 101.79%90萬 | -577,356.76%-2.14億 | ---- | ---- | 14.24%-6,646萬 | -9,871.98%-5,022.8萬 | 100.06%3.7萬 |
其他營業外收入(費用) | 302.48%187.5萬 | -42.54%169.8萬 | -289.29%-2,070.8萬 | 323.33%698.5萬 | -2,944.21%-2,972.2萬 | -125.60%-92.6萬 | -36.15%295.5萬 | -19.45%1,094萬 | -57.24%165萬 | 252.33%104.5萬 |
稅前利潤 | -31.26%6,215.2萬 | 419.15%3.89億 | 100.27%4.82億 | -22.30%1.96億 | 222.69%1.21億 | 222.89%9,041.9萬 | -53.20%7,495.5萬 | 89.18%2.41億 | -0.01%2.52億 | 5.73%-9,830.4萬 |
所得稅 | -130.86%-869.6萬 | 214.03%7,502.9萬 | 58.45%9,724.8萬 | -16.51%2,396.8萬 | 486.52%2,121.2萬 | 937.57%2,817.6萬 | -42.46%2,389.2萬 | 10.40%6,137.4萬 | -14.74%2,870.7萬 | -150.76%-548.8萬 |
除稅後利潤 | 13.83%7,084.8萬 | 515.12%3.14億 | 114.58%3.85億 | -23.04%1.72億 | 207.08%9,939.3萬 | 188.65%6,224.2萬 | -56.96%5,106.3萬 | 150.30%1.79億 | 2.26%2.24億 | 19.36%-9,281.7萬 |
持續經營利潤 | 13.82%7,084.8萬 | 515.12%3.14億 | 114.58%3.85億 | -23.04%1.72億 | 207.09%9,939.3萬 | 188.65%6,224.3萬 | -56.96%5,106.3萬 | 150.30%1.79億 | 2.26%2.24億 | 19.36%-9,281.6萬 |
歸屬于少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 13.83%7,084.8萬 | 515.12%3.14億 | 114.58%3.85億 | -23.04%1.72億 | 207.08%9,939.3萬 | 188.65%6,224.2萬 | -56.96%5,106.3萬 | 150.30%1.79億 | 2.26%2.24億 | 19.36%-9,281.7萬 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | 13.83%7,084.8萬 | 515.12%3.14億 | 114.58%3.85億 | -23.04%1.72億 | 207.08%9,939.3萬 | 188.65%6,224.2萬 | -56.96%5,106.3萬 | 150.30%1.79億 | 2.26%2.24億 | 19.36%-9,281.7萬 |
總派息金額 | ||||||||||
基本每股收益 | 13.97%4.57 | 515.20%20.24 | 119.06%24.82 | -21.26%11.11 | 210.90%6.41 | 198.77%4.01 | -53.40%3.29 | 207.05%11.33 | 25.09%14.11 | 2.69%-5.78 |
稀釋每股收益 | 17.29%4.5648 | 515.20%20.24 | 119.06%24.82 | -20.67%11.0983 | 203.27%6.2147 | 185.49%3.8918 | -53.40%3.29 | 207.05%11.33 | 27.94%13.9903 | -1.31%-6.0179 |
每股派息 | 0 | 0 | 60.00%8 | 60.00%8 | 0 | 0 | 0 | 25.00%5 | 25.00%5 | 0 |
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |